FDA
approval
· 2021-06-23
FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for doxazosin (doxazosin mesylate) from Mylan Pharmaceuticals. The drug is traditionally used to treat hypertension and …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DOXAZOSIN (DOXAZOSIN)